Operating

Write-offs

Pfizer Write-offs decreased by 99.3% to $32.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 90.7%, from $344.00M to $32.00M. Over 4 years (FY 2021 to FY 2025), Write-offs shows an upward trend with a 109.0% CAGR.

Analysis

StatementCash Flow Statement
SectionOperating
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
Metric ID: pfe_write_offs

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$31.00M$38.00M$183.00M$31.00M$27.00M$229.00M$263.00M$270.00M$57.00M$172.00M$2.91B$136.00M$295.00M$649.00M$3.16B$344.00M$154.00M$366.00M$4.41B$32.00M
QoQ Change+22.6%+381.6%-83.1%-12.9%+748.1%+14.8%+2.7%-78.9%+201.8%>999%-95.3%+116.9%+120.0%+387.2%-89.1%-55.2%+137.7%>999%-99.3%
YoY Change-12.9%+502.6%+43.7%+771.0%+111.1%-24.9%>999%-49.6%+417.5%+277.3%+8.7%+152.9%-47.8%-43.6%+39.3%-90.7%
Range$27.00M$4.41B
CAGR+0.7%
Avg YoY Growth+191.3%
Median YoY Growth+41.5%

Frequently Asked Questions

What is Pfizer's write-offs?
Pfizer (PFE) reported write-offs of $32.00M in Q1 2026.
How has Pfizer's write-offs changed year-over-year?
Pfizer's write-offs decreased by 90.7% year-over-year, from $344.00M to $32.00M.
What is the long-term trend for Pfizer's write-offs?
Over 4 years (2021 to 2025), Pfizer's write-offs has grown at a 109.0% compound annual growth rate (CAGR), from $276.00M to $5.27B.